日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TET1 deficiency amplifies macrophage inflammatory signaling associated with Crohn's disease.

TET1 缺陷会放大与克罗恩病相关的巨噬细胞炎症信号。

Perez Rocio K, Paul Reeba, Kumar Parveen, Tutkun Alp, Webb Deborah, McGorty Shea, Wieckowski Thomas, Yap Yoon Sing, Leesang Tiffany E, Vlantis Panayiotis I, Telonis Aristeidis G, Hajdin Christine, King Jim, Nabozny Gerald, Cimmino Luisa

Retinoic acid and ascorbate synergize to suppress myeloid leukemia via TET2 activation

视黄酸和抗坏血酸协同作用,通过激活TET2抑制髓系白血病。

Tiffany E Leesang ,John P Brabson ,Yoon Sing Yap ,Daniela A Barbieri ,Abigail S Klimas ,Joey Pinzone ,Emily L Ahearn ,Minh Q Lam ,Peter D Lyon ,Anna Swirski ,Nicholas B Wolfe ,Yuichiro Nakata ,Helena Gomes Dos Santos ,Ramin Shiekhattar ,Lluis Morey ,Panayiotis I Vlantis ,Maria E Figueroa ,Namrata Chandhok ,Felipe Beckedorff ,Aristeidis G Telonis ,Luisa Cimmino

B12 promotes gut dysbiosis and an inflammatory microenvironment that potentiates Tet2-deficient hematopoiesis

维生素B12促进肠道菌群失调和炎症微环境,从而增强Tet2缺陷型造血作用。

Lyon, P D; Leesang, T E; Brabson, J P; Do, Ktt; Dalzell, M; Nivelo, L A; Lam, M Q; Peci, A; Fang, B; Strippoli, V; Armand, A A; Singh, P K; Roy, S; Beckedorff, F; Villarino, A V; Cimmino, L

Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia

氧化型mC调节PARP抑制剂的合成致死性,用于治疗白血病

John P Brabson ,Tiffany Leesang ,Yoon Sing Yap ,Jingjing Wang ,Minh Q Lam ,Byron Fang ,Igor Dolgalev ,Daniela A Barbieri ,Victoria Strippoli ,Carolina P Bañuelos ,Sofia Mohammad ,Peter Lyon ,Sana Chaudhry ,Dane Donich ,Anna Swirski ,Evan Roberts ,Ivelisse Diaz ,Daniel Karl ,Helena Gomes Dos Santos ,Ramin Shiekhattar ,Benjamin G Neel ,Stephen D Nimer ,Ramiro E Verdun ,Daniel Bilbao ,Maria E Figueroa ,Luisa Cimmino